All news

US FDA closes inspection of Biocon’s insulin facility

02-Apr-2020 By Ben Hargreaves

The company announces that the problems raised by the FDA in February have been cleared.

Arch Venture raises $1.4bn fund to spur ‘healthcare revolution’

02-Apr-2020 By Ben Hargreaves

Arch Venture announces that it raised the sum across two funds, with the capital earmarked for early stage biotechs.

GE Healthcare Life Sciences completes transition into Cytiva

01-Apr-2020 By Ben Hargreaves

As Danaher’s $21bn acquisition completes, GE Life Sciences rebrands to ‘Cytiva’ and, with the COVID-19 pandemic, its CEO tells us demand is high.

Avectas partners with Vycellix to speed cell therapy production

31-Mar-2020 By Ben Hargreaves

The partners will combine expertise to progress the novel RNA immunomodulator, VY-M.

First US patient receives plasma therapy for coronavirus

31-Mar-2020 By Ben Hargreaves

FDA grants approval for the use of donated plasma from a recovered COVID-19 patient to be infused into a critically ill patient.

Latest industry developments against COVID-19

30-Mar-2020 By Ben Hargreaves

In the face of the threat from the novel coronavirus, industry momentum is gathering to produce a solution.

J&J chooses lead coronavirus candidate, sets up manufacturing for 1 billion doses

30-Mar-2020 By Ben Hargreaves

The company provides update on its coronavirus plans, which includes $1bn in funding to research and expected Phase I trial commencement date.

Takeda taps Evox for exosome therapeutics

30-Mar-2020 By Ben Hargreaves

The partners will focus on developing five potential exosome treatment for rare diseases.

Novartis’ gene therapy takes additional step towards EU approval

30-Mar-2020 By Ben Hargreaves

Zolgensma has received a recommendation for approval despite running into problems recently, including manufacturing questions and data integrity issues.

Gates Foundation in ‘unprecedented’ coronavirus partnership with industry

26-Mar-2020 By Ben Hargreaves

‘Collective action is critical,’ says Novartis CEO on industry partnership with Gates Foundation to accelerate treatments for COVID-19.

Astellas and CytomX team up to target solid tumors with T-cells

26-Mar-2020 By Ben Hargreaves

The two partners will work to develop clinical candidates for the treatment of cancer.

Roche ups Actemra production anticipating increased demand

25-Mar-2020 By Vassia Barba

Roche looks to maximize production of its arthritis treatment as the drug enters late-stage trials to evaluate its effectiveness against COVID-19.

BioStem adds R&D laboratory space to Florida site

25-Mar-2020 By Ben Hargreaves

BioStem announces expansion of its manufacturing facility to include an R&D laboratory to support its services for regenerative therapies.

Thermo Fisher to invest $475m into biopharma in 2020

25-Mar-2020 By Ben Hargreaves

Continuing a trend among larger CDMOs, Thermo Fisher reveals scale of investment into biopharma business and further focus on cell and gene therapy.

ProBioGen, Immunogenesis in cell line development agreement

24-Mar-2020 By Vassia Barba

Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.